To confirm invasion inhibition ability, molecular markers were analyzed for invasion, and Western blotting analysis of MMP2, MMP9, and VEGF also confirmed that silibinin could reduce angiogenesis, progression, and metastasis of NSCLC (Figure 3C). The gene discussed is MMP2; the disease is non-small cell lung carcinoma.